Heart Disease Trial, Recruiting NCT06657833 Sponsor: Fundación EPIC Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06657833
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years old and have been admitted to hospital with either stable heart disease or an urgent heart condition, and your doctors have decided you need a procedure to open a blocked or narrowed heart artery (called PCI).
  • During imaging inside your heart artery, doctors have found a specific type of hard, calcium-containing blockage called a "calcified nodule," confirmed by a specialised camera or ultrasound probe placed inside the artery.
  • The artery being treated measures between 2.5 and 4 mm in diameter.

Who may not be able to join:

  • You are unable or unwilling to give written and spoken consent to take part, or you are not able to return for follow-up check-up scans as required by the trial.
  • You are currently pregnant or breastfeeding.
  • You are in a state of severe heart failure causing the body to shut down (cardiogenic shock) or you have had a cardiac arrest at the time of the procedure.
  • You are unable to take two blood-thinning medicines together for at least one month after the procedure.
  • Your doctors estimate your life expectancy is less than one year.
  • The artery blockage being treated is in a specific location called the "left main stem" (the main artery branching off the heart).
  • The blockage is located right at the point where the artery connects to the main large blood vessel (the aorta).
  • The artery being treated has already had a stent or a special drug-coated balloon placed in it previously.
  • There is a large amount of blood clot present in the target artery blockage (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0034987225638

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundación EPIC
Registry
ClinicalTrials.gov
Start date
17 December 2024
Est. completion
30 October 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

EFFICACY: Late Lumen Loss (LLL); EFFICACY: Net Lumen Gain (NLG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov